Results 341 to 350 of about 290,304 (371)
Some of the next articles are maybe not open access.
Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multice
The Lancet Oncology, 2016 S. Al-Batran, R. Hofheinz, C. Pauligk, H. Kopp, G. Haag, K. Luley, J. Meiler, N. Homann, S. Lorenzen, H. Schmalenberg, S. Probst, M. Koenigsmann, M. Egger, N. Prasnikar, K. Caca, J. Trojan, U. Martens, A. Block, W. Fischbach, R. Mahlberg, M. Clemens, G. Illerhaus, K. Zirlik, D. Behringer, W. Schmiegel, M. Pohl, M. Heike, U. Ronellenfitsch, M. Schuler, W. Bechstein, A. Königsrainer, T. Gaiser, P. Schirmacher, W. Hozaeel, Alexander Reichart, T. Goetze, M. Sievert, E. Jäger, S. Mönig, A. Tannapfel +39 moresemanticscholar +1 more source
